Hepatitis C Virus 2024: From Prevention to Management
Nov
16
2024
Convention Center: Room 29
2:00 PM - 3:30 PM
Captured
World Class Speakers
Description
Experts review and discuss the most up-to-date information on rapid, point-of-care HCV diagnostic strategies; HCV vaccine development and its importance in achieving the goal of HCV elimination; and the management of special populations with chronic HCV infection including difficult-to-treat or hard-to-reach persons.Journey Maps
Presentations
2:00 PM - 2:20 PM
Nov
16
2024
San Diego, CA
New Diagnostic and Guideline Developments Advancing Hepatitis C Elimination in the United States
Carolyn Wester, MD, MPH, Presenter
Hepatitis
2:20 PM - 2:40 PM
Nov
16
2024
San Diego, CA
Veterans Affairs Health Care System Experience: Successful Strategies in Eradicating Hepatitis C Virus
Debika Bhattacharya, MD, MSc, Presenter
Hepatitis
2:40 PM - 3:00 PM
Nov
16
2024
San Diego, CA
Impact of Treating Substance Use and Harm Reduction on Hepatitis C Virus Elimination
Brian Pearlman, MD, FAASLD, FACP, AAHIVS, Presenter
Hepatitis
3:00 PM - 3:20 PM
Nov
16
2024
San Diego, CA
New Opportunities in Hepatitis C Virus Vaccine Development
Jake T Liang, MD, Presenter
Hepatitis
Objectives
- Review available technologies for point-of-care HCV testing and their successful implementation in the United States and other countries.
- Discuss treatment and retreatment strategies with direct-acting antivirals in difficult-to-treat or hard-to-reach HCV-infected persons.
- Analyze the role of HCV vaccine development in achieving HCV elimination.
Chair
Harrys A Torres, MD, FAASLD
The University of Texas MD Anderson Cancer Center